Targeting Bcl-2 Enhances the Anti-Tumor Effects of Lenalidomide and Dexamethasone in in Vitro and In Vivo Models of Multiple Myeloma

被引：2
|
作者：
Paulus, Aneel [1 ]
Akhtar, Sharoon [2 ]
Bashir, Yamima [2 ]
Paulus, Shumail M. [1 ]
Menghani, Richa [1 ]
Roy, Vivek [3 ]
Ailawadhi, Sikander [3 ]
Chanan-Khan, Asher A. [3 ]
机构：
[1] Mayo Clin, Div Hematol & Oncol, Jacksonville, FL USA
[2] Mayo Clin, Jacksonville, FL USA
[3] Mayo Clin, Div Hematol, Jacksonville, FL USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.4480.4480
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4480
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Combinations of belantamab mafodotin with lenalidomide, pomalidomide, bortezomib and/or dexamethasone synergize in vitro and potentiate in vivo anti-tumor activity in multiple myeloma
    De Oca, Rocio Montes
    Gupta, Ira
    Shelton, Chris
    CANCER RESEARCH, 2020, 80 (16)
  • [2] Targeting Bcl-2 for the treatment of multiple myeloma
    Cyrille Touzeau
    Paulo Maciag
    Martine Amiot
    Philippe Moreau
    Leukemia, 2018, 32 : 1899 - 1907
  • [3] Targeting Bcl-2 for the treatment of multiple myeloma
    Touzeau, Cyrille
    Maciag, Paulo
    Amiot, Martine
    Moreau, Philippe
    LEUKEMIA, 2018, 32 (09) : 1899 - 1907
  • [4] Dual-Inhibition of mTOR and Bcl-2 Enhances the Anti-tumor Effect of Everolimus against Renal Cell Carcinoma In Vitro and In Vivo
    Nayman, Ayse Hande
    Siginc, Halime
    Zemheri, Ebru
    Yencilek, Faruk
    Yildirim, Asif
    Telci, Dilek
    JOURNAL OF CANCER, 2019, 10 (06): : 1466 - 1478
  • [5] In vivo anti-tumor activity of atiprimod on SCID models of multiple myeloma.
    Neri, P
    Tassone, P
    Shammas, MA
    Batchu, RB
    Blotta, S
    Samala, S
    Catley, L
    Hamasaki, M
    Hideshima, T
    Jacob, GS
    Picker, DH
    Venuta, S
    Anderson, KC
    Munshi, NC
    BLOOD, 2005, 106 (11) : 76A - 76A
  • [6] Targeting Bcl-2 as therapy for multiple myeloma.
    Chauhan, D
    Velankar, M
    Hideshima, T
    Mitsiades, C
    Catley, L
    Raje, N
    Schlossman, R
    Richardson, P
    Anderson, KC
    BLOOD, 2005, 106 (11) : 36A - 36A
  • [7] Targeting Tryptophan Catabolic Kynurenine Pathway Enhances Anti-Tumor Immunity and Cytotoxicity in Multiple Myeloma
    Ray, Arghya
    Song, Yan
    Chauhan, Dharminder
    Anderson, Kenneth C.
    BLOOD, 2018, 132
  • [8] Epigallocatechin gallate with photodynamic therapy enhances anti-tumor effects in vivo and in vitro
    Mun, Seong Taek
    Bae, Dong Han
    Ahn, Woong Shick
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2014, 11 (02) : 141 - 147
  • [9] Mir-29a Displays in Vitro and in Vivo Anti-Tumor Activity in Multiple Myeloma
    Saha, Manujendra N.
    Chen, Yan
    Abdi, Jahangir
    Chang, Hong
    BLOOD, 2014, 124 (21)
  • [10] Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma
    Kaufman, Jonathan L.
    Gasparetto, Cristina
    Schjesvold, Fredrik H.
    Moreau, Philippe
    Touzeau, Cyrille
    Facon, Thierry
    Boise, Lawrence H.
    Jiang, Yanwen
    Yang, Xiaoqing
    Dunbar, Fengjiao
    Vishwamitra, Deeksha
    Unger, Stefanie
    Macartney, Tammy
    Pesko, John
    Yu, Yao
    Salem, Ahmed Hamed
    Ross, Jeremy A.
    Hong, Wan-Jen
    Maciag, Paulo C.
    Pauff, James M.
    Kumar, Shaji
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (04) : 418 - 427
12345